Pemetrexed Continuation Maintenance versus Conventional Platinum-based Doublet Chemotherapy in EGFR-negative Lung Adenocarcinoma: Retrospective Analysis

被引：0
|
作者：
Hwang, I. K. [1 ]
Paik, S. S. [1 ]
Park, M. J. [2 ]
Lee, S. H. [2 ]
机构：
[1] Dongnam Inst Radiol & Med Sci, Dept Internal Med, Busan, South Korea
[2] Kyung Hee Univ, Med Ctr, Dept Internal Med, Seoul, South Korea
来源：
JOURNAL OF THORACIC ONCOLOGY | 2017年 / 12卷 / 11期
关键词：
pemetrexed; chemotherapy; Platinum;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P2.03-020
引用
收藏
页码：S2134 / S2134
页数：1
相关论文
共 50 条
  • [11] A Three-microRNA Signature Predicts Responses to Platinum-Based Doublet Chemotherapy in Patients with Lung Adenocarcinoma
    Saito, Motonobu
    Shiraishi, Kouya
    Matsumoto, Kenji
    Schetter, Aaron J.
    Ogata-Kawata, Hiroko
    Tsuchiya, Naoto
    Kunitoh, Hideo
    Nokihara, Hiroshi
    Watanabe, Shun-ichi
    Tsuta, Koji
    Kumamoto, Kensuke
    Takenoshita, Seiichi
    Yokota, Jun
    Harris, Curtis C.
    Kohno, Takashi
    CLINICAL CANCER RESEARCH, 2014, 20 (18) : 4784 - 4793
  • [12] CLINICAL FACTORS ASSOCIATED WITH THE EFFICACY OF PEMETREXED AS CONTINUATION MAINTENANCE CHEMOTHERAPY IN PATIENTS WITH ADVANCED LUNG ADENOCARCINOMA
    Chen, Chung-Yu
    Chen, Kuan-Yu
    Yu, Chong-Jen
    Yang, Pan-Chyr
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S587 - S587
  • [13] Pemetrexed Combined with Platinum-based Chemotherapy for Advanced Malignant Peritoneal Mesothelioma: Retrospective Analysis of Six Cases
    Nakano, Michitaka
    Kusaba, Hitoshi
    Makiyama, Akitaka
    Ariyama, Hiroshi
    Arita, Shuji
    Oda, Hisanobu
    Esaki, Taito
    Takayoshi, Kotoe
    Uchino, Keita
    Tamura, Shingo
    Kumagai, Hozumi
    Iwama, Eiji
    Shirakawa, Tsuyoshi
    Mitsugi, Kenji
    Takaishi, Shigeo
    Akashi, Koichi
    Baba, Eishi
    ANTICANCER RESEARCH, 2014, 34 (1A) : 215 - 220
  • [14] Prediction of response and adverse drug reaction of pemetrexed plus platinum-based chemotherapy in lung adenocarcinoma by serum metabolomic profiling
    Gong, Wei-Jing
    Cao, Peng
    Zhang, Qi-Lin
    Han, Xiao-Yu
    Wang, Shuo-Wen
    Huang, Yi-Fei
    Wu, San-Lan
    Li, Qiang
    Zhang, Rui
    Xu, Shuang-Bing
    Liu, Ya-Ni
    Shi, Shao-Jun
    Zhang, Yu
    TRANSLATIONAL ONCOLOGY, 2022, 19
  • [15] A RETROSPECTIVE ANALYSIS OF PLATINUM-BASED NEOADJUVANT CHEMOTHERAPY FOR LATNBC
    Fei, F.
    Du, Y.
    Di, G.
    Lu, J.
    Wu, J.
    Shao, Z.
    BREAST, 2013, 22 : S98 - S98
  • [16] Impact of EGFR mutation status in patients with completely resected lung adenocarcinoma treated with adjuvant platinum-based chemotherapy
    Yoh, K.
    Goto, K.
    Niho, S.
    Ohmatsu, H.
    Nagai, K.
    Ohe, Y.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [17] Pemetrexed-based chemotherapy in advanced lung adenocarcinoma patients with different EGFR genotypes
    Jiang, Xiangli
    Yang, Bo
    Lu, Jiuqin
    Zhan, Zhongli
    Li, Kai
    Ren, Xiubao
    TUMOR BIOLOGY, 2015, 36 (02) : 861 - 869
  • [18] A RETROSPECTIVE ANALYSIS OF PLATINUM-BASED NEOADJUVANT CHEMOTHERAPY FOR LOCAL ADVANCED TRIPLE NEGATIVE BREAST CANCER
    Fei, F.
    Du, Y.
    Gu, X.
    Chen, C.
    Wu, J.
    Shao, Z.
    ANNALS OF ONCOLOGY, 2012, 23 : 130 - 130
  • [19] Efficacy of Joungal in preventing febrile neutropenia induced by platinum-based doublet chemotherapy in lung cancer
    Zeng, Fanxu
    Li, Ting
    Xia, Chen
    Chen, Gong
    Sun, Ziyi
    Guan, Rui
    Lizaso, Analyn
    Mao, Xinru
    Li, Kunyan
    Zhang, Yongchang
    ANNALS OF PALLIATIVE MEDICINE, 2020, 9 (04) : 1688 - +
  • [20] Platinum-based Doublet Chemotherapy plus Bevacizumab Without Bevacizumab Maintenance in Advanced Non-small Cell Lung Cancer (NSCLC)
    Noroxe, Dorte Schou
    Wallerek, Sandra
    Sorensen, Jens Benn
    ANTICANCER RESEARCH, 2013, 33 (08) : 3275 - 3278
12345